Palbociclib in combination with anastrozole or exemestane for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany. Interim results of the INGE-B phase 2 trial.

13. Dezember 2019

M. Welslau, N. Marschner, U. Söling, C. Brucker, O.J. Stoetzer, J. Meiler, P.Wimberger, S.Dörfel, J.Sahlmann, L.Houet, C.Vannier, K.Potthoff, 2019.

Cancer Res February 15 2020 (80) (4 Supplement) P5-11-14